BlackRock Investment Management, LLC - EVOKE PHARMA INC ownership

EVOKE PHARMA INC's ticker is EVOK and the CUSIP is 30049G104. A total of 12 filers reported holding EVOKE PHARMA INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of EVOKE PHARMA INC
ValueSharesWeighting
Q4 2016$3,0000.0%1,2850.0%0.00%
Q3 2016$3,000
-40.0%
1,285
+76.5%
0.00%
Q2 2016$5,000
+150.0%
728
+48.9%
0.00%
Q1 2016$2,0000.0%4890.0%0.00%
Q4 2015$2,000
+100.0%
4890.0%0.00%
Q3 2015$1,000
-66.7%
4890.0%0.00%
Q2 2015$3,0000.0%4890.0%0.00%
Q1 2015$3,0000.0%4890.0%0.00%
Q4 2014$3,0000.0%4890.0%0.00%
Q3 2014$3,000
-25.0%
4890.0%0.00%
Q2 2014$4,0004890.00%
Other shareholders
EVOKE PHARMA INC shareholders Q1 2016
NameSharesValueWeighting ↓
Wambolt & Associates, LLC 33,165$29,0000.02%
STATE OF MICHIGAN RETIREMENT SYSTEM 400,000$344,0000.00%
A.R.T. Advisors, LLC 36,954$32,0000.00%
NORTHERN TRUST CORP 33,997$29,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 199,678$171,0000.00%
CITIGROUP INC 500$00.00%
MORGAN STANLEY 1,450$1,0000.00%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 36,700$32,0000.00%
BlackRock Inc. 54,940$47,0000.00%
View complete list of EVOKE PHARMA INC shareholders